| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.043 | 0.8 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.041 | 0.8 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.035 | 0.8 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.034 | 0.8 |